Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

The feds are looking to score 650 kilos of weed

A medical marijuana operation in Colorado.
A medical marijuana operation in Colorado.
A medical marijuana operation in Colorado.
The Washington Post via Getty Images

The Drug Enforcement Administration on August 26 massively boosted how much marijuana the federal government can grow for researchers in 2014.

The increase, from 21 kilograms to 650, will allow the already-approved University of Mississippi and perhaps other organizations — if they get federal approval — to grow substantially more research-bound marijuana for the National Institute on Drug Abuse (NIDA).

A NIDA spokesperson previously explained in an email that the boost will accommodate researchers’ increased demand for marijuana.

This is a big deal: it means the federal government is moving closer and closer to accepting marijuana for research and, potentially, medical purposes. It’s worth noting, however, that substantial regulatory barriers remain, even though there is some evidence marijuana can treat some medical conditions better than conventional medicine.

The nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), which has been pushing the federal government to loosen its restrictions on marijuana, was quick to point out that NIDA still holds a monopoly over marijuana for research. MAPS President Rick Doblin said his organization will continue working to end that monopoly.

Researchers often complain that, as a result of NIDA’s monopoly, they’ve had to abide to extra regulatory hurdles to conduct medical marijuana research. The process can extend a study’s approval by months or even years, on top of the Food and Drug Administration process that medical drug research typically goes through.

The monopoly also puts medical marijuana in a contradictory legal area: it’s legal, at least in some states, for private growers to supply marijuana for medical consumption, but it’s not possible for researchers to go to the same private growers to find out if the marijuana is safe for medical consumption in the first place.

Policy
The Supreme Court will decide if marijuana users may be barred from owning gunsThe Supreme Court will decide if marijuana users may be barred from owning guns
Policy

Do stoners have a right to bear arms?

By Ian Millhiser
Politics
3 winners and 1 loser from Election Day 20233 winners and 1 loser from Election Day 2023
Politics

Democrats had a good night. So did abortion rights. Glenn Youngkin, not so much.

By Andrew Prokop
Money
Is CBD in trouble?Is CBD in trouble?
Money

The FDA just refused to regulate the popular cannabis product as a dietary supplement. So, uh, buyer beware?

By Mary Jane Gibson
Money
Is legal weed doomed to be run by big business?Is legal weed doomed to be run by big business?
Money

Pro-marijuana advocates have become surprising foes of some efforts to legalize. Here’s why.

By Mary Jane Gibson
Video
A fact-checked debate about legal weedA fact-checked debate about legal weed
Play
Video

Two opposing perspectives and six true facts about cannabis legalization.

By Joss Fong and Laura Bult
The 2022 midterm elections, explained
A mixed night for marijuana on the ballotA mixed night for marijuana on the ballot
The 2022 midterm elections, explained

Victories in Maryland and Missouri, losses in Arkansas and the Dakotas.

By Mary Jane Gibson